Private Trust Company’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-334
Closed -$4.86K 2564
2025
Q3
$4.86K Sell
334
-167
-33% -$2.38K ﹤0.01% 2157
2025
Q2
$9.79K Hold
501
﹤0.01% 1831
2025
Q1
$8.89K Buy
501
+44
+10% +$948 ﹤0.01% 1841
2024
Q4
$9.78K Buy
457
+142
+45% +$3.45K ﹤0.01% 1757
2024
Q3
$9.84K Buy
315
+91
+41% +$2.26K ﹤0.01% 1737
2024
Q2
$3.48K Buy
+224
New +$2.71K ﹤0.01% 2044
2022
Q4
Sell
-150
Closed -$3K 2176
2022
Q3
$3K Sell
150
-56
-27% -$1.2K ﹤0.01% 1790
2022
Q2
$4K Buy
+206
New +$5.71K ﹤0.01% 1793

Other funds holding CDNA

Private Trust Company's CDNA Position: Q4 2025 in Review

Private Trust Company sold out of CareDx (CDNA) in Q4 2025, closing a stake of 334 shares — an estimated $4.86K sold.

Private Trust Company first reported a position in CDNA in Q2 2022 and held it in 8 quarters. The position peaked at $9.84K in Q3 2024. 200 funds tracked by Wall St. Rank hold CDNA as of Q4 2025.

  • Private Trust Company reported no remaining CareDx position as of Q4 2025 after selling out during the quarter.
  • Private Trust Company sold 334 CareDx shares in Q4 2025, an estimated $4.86K.
  • Private Trust Company first reported a position in CareDx in Q2 2022 and held it in 8 quarters.
  • Private Trust Company's CareDx position peaked at $9.84K in Q3 2024.
  • 200 funds tracked by Wall St. Rank held CareDx as of Q4 2025.

Based on Private Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.